Minireview: The AMP-Activated Protein Kinase Cascade: The Key Sensor of Cellular Energy Status

Endocrinology

Volumn 144, Issue 12, 2003, Pages 5179-5183

  Hardie, D Grahame ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ADIPONECTIN; ANTIDIABETIC AGENT; CARBOHYDRATE; GLUCOSE; LEPTIN; LIPID; METFORMIN; ROSIGLITAZONE;

BIOSENSOR; CATABOLISM; CELL ACTIVITY; CELL ENERGY; CELL SURVIVAL; DOWNSTREAM PROCESSING; DRUG TARGETING; ENZYME ACTIVATION; ENZYME REGULATION; EXERCISE; HUMAN; HYPOXIA; IN VIVO STUDY; ISCHEMIA; LIPOGENESIS; METABOLIC DISORDER; MOLECULAR DYNAMICS; MUSCLE CONTRACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SHORT SURVEY; STRESS; TREATMENT INDICATION;

ANIMALS; ENERGY METABOLISM; EUKARYOTIC CELLS; HUMANS; MULTIENZYME COMPLEXES; PROTEIN-SERINE-THREONINE KINASES;

EID: 0344081177     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0982     Document Type: Short Survey

References (66)

1. Beg ZH, Allmann DW, Gibson DM 1973 Modulation of 3-hydroxy-3- methylglutaryl coenzyme A reductase activity with cAMP and with protein fractions of rat liver cytosol. Biochem Biophys Res Commun 54:1362-1369
2. Carlson CA, Kim KH 1973 Regulation of hepatic acetyl coenzyme A carboxylase by phosphorylation and dephosphorylation. J Biol Chem 248:378-380
3. Carling D, Zammit VA, Hardie DG 1987 A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett 223:217-222
4. Sim ATR, Hardie DG 1988 The low activity of acetyl-CoA carboxylase in basal and glucagon-stimulated hepatocytes is due to phosphorylation by the AMP-activated protein kinase and not cyclic AMP-dependent protein kinase. FEBS Lett 233:294-298
5. Hardie DG, Carling D, Sim ATR 1989 The AMP-activated protein kinase - a multisubstrate regulator of lipid metabolism. Trends Biochem Sci 14:20-23
6. Hardie DG, Scott JW, Pan DA, Hudson ER 2003 Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 546:113-120
7. Woods A, Salt I, Scott J, Hardie DG, Carling D 1996 The α1 and α2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett 397:347-351
8. Thornton C, Snowden MA, Carling D 1998 Identification of a novel AMP-activated protein kinase β subunit isoform which is highly expressed in skeletal muscle. J Biol Chem 273:12443-12450
9. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, House CM, Fernandez CS, Cox T, Witters LA, Kemp BE 1996 Mammalian AMP-activated protein kinase subfamily. J Biol Chem 271:611-614
10. Cheung PCF, Salt IP, Davies SP, Hardie DG, Carling D 2000 Characterization of AMP-activated protein kinase y subunit isoforms and their role in AMP binding. Biochem J 346:659-669
11. Salt I, Celler JW, Hawley SA, Prescott A, Woods A, Carling D, Hardie DG 1998 AMP-activated protein kinase - greater AMP dependence, and preferential nuclear localization, of complexes containing the α2 isoform. Biochem J 334:177-187
12. Ai H, Ihlemann J, Hellsten Y, Lauritzen HP, Hardie DG, Galbo H, Ploug T 2002 Effect of fiber type and nutritional state on AICAR-and contraction-stimulated glucose transport in rat muscle. Am J Physiol 282:E1291-E1300
13. da Silva Xavier G, Leclerc I, Salt IP, Doiron B, Hardie DG, Kahn A, Rutter GA 2000 Role of the AMP-activated protein kinase in the regulation by glucose of islet β-cell gene expression. Proc Natl Acad Sci USA 97:4023-4028
14. Turnley AM, Stapleton D, Mann RJ, Witters LA, Kemp BE, Bartlett PF 1999 Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J Neurochem 72:1707-1716
15. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG 1996 Characterization of the AMP-activated protein kinase kinase from rat liver, and identification of threonine-172 as the major site at which it phosphorylates and activates AMP-activated protein kinase. J Biol Chem 271:27879-27887
16. Stein SC, Woods A, Jones NA, Davison MD, Carling D 2000 The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345:437-443
17. 2+/calmodulin the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J Biol Chem 270:27186-27191
18. c. FEBS Lett 377:421-425
19. Hardie DG, Salt IP, Hawley SA, Davies SP 1999 AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J 338:717-722
20. Hardie DG, Hawley SA 2001 AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23:1112-1119
21. Corton JM, Gillespie JG, Hardie DG 1994 Role of the AMP-activated protein kinase in the cellular stress response. Curr Biol 4:315-324
22. Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD 1995 High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of aceryl-CoA carboxylase. J Biol Chem 270:17513-17520
23. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, Van den Berghe G, Carling D, Hue L 2000 Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 10:1247-1255
24. Salt IP, Johnson G, Ashcroft SJH, Hardie DG 1998 AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic β cells, and may regulate insulin release. Biochem J 335:533-539
25. Winder WW, Hardie DG 1996 Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 270:E299-E304
26. Hutber CA, Hardie DG, Winder WW 1997 Electrical stimulation inactivates muscle aceryl-CoA carboxylase and increases AMP-activated protein kinase activity. Am J Physiol 272:E262-E266
27. Vavvas D, Apazidis A, Saha AK, Gamble J, Patel A, Kemp BE, Witters LA, Ruderman NB 1997 Contraction-induced changes in aceryl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J Biol Chem 272:13255-13261
28. Fujii N, Hayashi T, Hirshman MF, Smith JT, Habinowski SA, Kaijser L, Mu J, Ljungqvist O, Birnbaum MJ, Witters LA, Thorell A, Goodyear LJ 2000 Exercise induces isoform-specific increase in 5′ AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 273:1150-1155
29. Wojtaszewski JF, Nielsen P, Hansen BF, Richter EA, Kiens B 2000 Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle. J Physiol 528:221-226
30. Rasmussen BB, Winder WW 1997 Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase. J Appl Physiol 83:1104-1109
31. Stephens TJ, Chen ZP, Canny BJ, Michell BJ, Kemp BE, McConell GK 2002 Progressive increase in human skeletal muscle AMPK α2 activity and ACC phosphorylation during exercise. Am J Physiol 282:E688-E694
32. Ponticos M, Lu QL, Morgan JE, Hardie DG, Partridge TA, Carling D 1998 Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J 17:1688-1699
33. Hudson ER, Pan DA, James J, Lucocq JM, Hawley SA, Green KA, Baba O, Terashima T, Hardie DG 2003 A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr Biol 13:861-866
34. Polekhina G, Gupta A, Michell BJ, van Denderen B, Murthy S, Feil SC, Jennings IG, Campbell DJ, Witters LA, Parker MW, Kemp BE, Stapleton D 2003 AMPK β-subunit targets metabolic stress-sensing to glycogen. Curr Biol 13:867-871
35. Wojtaszewski JFP, Jørgensen SB, Hellsten Y, Hardie DG, Richter EA 2002 Glycogen-dependent effects of AICA riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 51:284-292
36. Wojtaszewski JF, MacDonald C, Nielsen JN, Hellsten Y, Hardie DG, Kemp BE, Kiens B, Richter EA 2002 Regulation of 5′ AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol 284:E813-E822
37. q-coupled receptors. Biochem Biophys Res Commun 276: 16-22
38. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB 2002 Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339-343
39. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295
40. Corton JM, Gillespie JG, Hawley SA, Hardie DG 1995 5-Aminoimidazole-4- carboxamide ribonucleoside: a specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229:558-565
41. Henin N, Vincent MF, Gruber HE, Van den Berghe G 1995 Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J 9:541-546
42. Longnus SL, Wambolt RB, Parsons HL, Brownsey RW, Allard MF 2003 5-Aminoimidazole-4-carboxamide 1-β-D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms. Am J Physiol 284:R936-R944
43. Vincent MF, Marangos PJ, Gruber HE, Van den Berghe G 1991 Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes. Diabetes 40: 1259-1266
44. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE 2001 Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174
45. Fryer LG, Parbu-Patel A, Carling D 2002 The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct pathways. J Biol Chem 277:25226-25232
46. Hawley SA, Gadalla AE, Olsen GS, Hardie DG 2002 The anti-diabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51:2420-2425
47. Hardie DG, Pan DA 2002 Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 30:1064-1070
48. Horman S, Browne G, Krause U, Patel J, Vertommen D, Bertrand L, Lavoinne A, Hue L, Proud C, Rider M 2002 Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr Biol 12:1419-1423
49. Bolster DR, Crozier SJ, Kimball SR, Jefferson LS 2002 AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through downregulated mTOR signaling. J Biol Chem 277:23977-23980
50. McLeod LE, Proud CG 2002 ATP depletion increases phosphorylation of elongation factor eEF2 in adult cardiomyocytes independently of inhibition of mTOR signalling. FEBS Lett 531:448-452
51. Dubbelhuis PF, Meijer AJ 2002 Hepatic amino acid-dependent signaling is under the control of AMP-dependent protein kinase. FEBS Lett 521:39-42
52. Krause U, Bertrand L, Hue L 2002 Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes. Eur J Biochem 269:3751-3759
53. Hallows KR, Raghuram V, Kemp BE, Witters LA, Foskett JK 2000 Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase. J Clin Invest 105: 1711-1721
54. Hallows KR, McCane JE, Kemp BE, Witters LA, Foskett JK 2003 Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells. J Biol Chem 278:998-1004
55. Hallows KR, Kobinger GP, Wilson JM, Witters LA, Foskett JK 2003 Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells. Am J Physiol 284:C1297-C1308
56. Mu J, Barton ER, Birnbaum MJ 2003 Selective suppression of AMP-activated protein kinase in skeletal muscle: update on "lazy mice." Biochem Soc Trans 31:236-241
57. Zong H, Ren JM, Young LH, Pypaert M, Mu J, Birnbaum MJ, Shulman GI 2002 AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci USA 99:15983-15987
58. Kawaguchi T, Osatomi K, Yamashita H, Kabashima T, Uyeda K 2001 Mechanism for fatty acids sparing effect on glucose-induced transcription: regulation of carbohydrate response element binding protein by AMP-activated protein kinase. J Biol Chem 277:3829-3835
59. Yang W, Hong YH, Shen XQ, Frankowski C, Camp HS, Leff T 2001 Regulation of transcription by AMP-activated protein kinase. Phosphorylation of p300 blocks its interaction with nuclear receptors. J Biol Chem 276:38341-38344
60. Leclerc I, Lenzner C, Gourdon L, Vaulont S, Kahn A, Viollet B 2001 Hepatocyte nuclear factor-4α involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase. Diabetes 50:1515-1521
61. Habinowski SA, Witters LA 2001 The effects of AICAR on adipocyte differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 286:852-856
62. Hong YH, Varanasi US, Yang W, Leff T 2003 AMP-activated protein kinase regulates HNF4α transcriptional activity by inhibiting dimer formation and decreasing protein stability. J Biol Chem 278:27495-27501
63. Song XM, Fiedler M, Galuska D, Ryder JW, Fernstrom M, Chibalin AV, Wallberg-Henriksson H, Zierath JR 2002 5-Aminoimidazole-4-caboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice. Diabetologia 45:56-65
64. Buhl ES, Jessen N, Fold R, Ledet T, Flyvbjerg A, Pedersen SB, Pedersen O, Schmitz O, Lund S 2002 Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 51:2199-2206
65. Iglesias MA, Ye JM, Frangioudakis G, Saha AK, Tomas E, Ruderman NB, Cooney GJ, Kraegen EW 2002 AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes 51:2886-2894
66. Bergeron R, Previs SF, Cline GW, Perret P, Russell 3rd RR, Young LH, Shulman GI 2001 Effect of 5-aminoimidazole-4-carboxamide-1-β-D- ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes 50:1076-1082